Valuation : Boule Diagnostics AB

Market Cap 122M 12.69M 10.92M 10.26M 9.36M 17.59M 1.21B 17.72M 47.29M 612M 47.64M 46.6M 2.03B P/E 2026 *
-12.4x
P/E 2027 * 14.1x
Enterprise Value 318M 33.2M 28.59M 26.84M 24.5M 46.03M 3.16B 46.36M 124M 1.6B 125M 122M 5.3B EV / Sales 2026 *
0.7x
EV / Sales 2027 * 0.63x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-1.92%
1 week-4.36%
Current month-19.63%
1 month-19.63%
3 months-5.83%
6 months-24.57%
Current year-37.47%
1 week 3.07
Extreme 3.07
3.28
1 month 3.07
Extreme 3.07
3.91
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
59.5
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 21/06/2026
Director of Finance/CFO 54 10/02/2026
Chief Tech/Sci/R&D Officer - 31/12/2018
Director TitleAgeSince
Director/Board Member 59 31/12/2013
Chairman 73 31/12/2020
Chairman 74 31/12/2022
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-1.92%-4.36%-49.00%-68.67% 12.69M
-0.82%-1.85%+25.24%+10.77% 228B
-1.16%-0.72%+3.76%-19.41% 150B
+1.14%+0.88%-19.66%+20.53% 133B
+3.12%-1.45%-54.22%-10.46% 70B
+0.60%+0.28%+11.57%+18.67% 52.31B
+0.52%-2.57%-17.51%-14.92% 50.59B
-0.18%+0.08%+22.20%+26.84% 43.3B
-0.01%+0.94%+37.39%+47.66% 40.74B
-0.10%+3.29%-12.54%+50.45% 34.63B
Average -0.19%-0.93%-5.28%+6.15% 80.3B
Weighted average by Cap. -0.18%-1.02%+2.09%+8.24%

Financials

2026 *2027 *
Net sales 453M 47.3M 40.72M 38.24M 34.91M 65.57M 4.5B 66.04M 176M 2.28B 178M 174M 7.56B 483M 50.45M 43.44M 40.79M 37.23M 69.95M 4.8B 70.45M 188M 2.43B 189M 185M 8.06B
Net income -9.77M -1.02M -878K -825K -753K -1.41M -97.07M -1.42M -3.8M -49.22M -3.83M -3.75M -163M 8.6M 897K 773K 725K 662K 1.24M 85.38M 1.25M 3.34M 43.29M 3.37M 3.3M 143M
Net Debt 197M 20.52M 17.66M 16.59M 15.14M 28.44M 1.95B 28.65M 76.47M 990M 77.03M 75.36M 3.28B 185M 19.26M 16.58M 15.57M 14.21M 26.7M 1.83B 26.89M 71.79M 929M 72.32M 70.75M 3.08B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
01/09/26 SEK 3.070 -1.92% 4,367
31/08/26 SEK 3.130 -1.26% 38,909
28/08/26 SEK 3.170 +1.60% 32,422
27/08/26 SEK 3.120 -0.32% 27,493
26/08/26 SEK 3.130 -1.88% 36,335
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.130SEK
Average target price
3.800SEK
Spread / Average Target
+21.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock